Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus

NCT01313923 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Lack of funding

Conditions

Pemphigus

Interventions

DRUG: Sirolimus (formerly known as Rapamycin)

Sponsor

University of California, Irvine